0001209191-19-020454.txt : 20190319
0001209191-19-020454.hdr.sgml : 20190319
20190319184241
ACCESSION NUMBER: 0001209191-19-020454
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190318
FILED AS OF DATE: 20190319
DATE AS OF CHANGE: 20190319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pla Frederic
CENTRAL INDEX KEY: 0001649167
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51541
FILM NUMBER: 19693019
MAIL ADDRESS:
STREET 1: C/O GENOMIC HEALTH, INC.
STREET 2: 101 GALVESTON DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063-4700
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENOMIC HEALTH INC
CENTRAL INDEX KEY: 0001131324
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770552594
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-556-9300
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-18
0
0001131324
GENOMIC HEALTH INC
GHDX
0001649167
Pla Frederic
301 PENOBSCOT DR.
REDWOOD CITY
CA
94063
0
1
0
0
COO
Common Stock
2019-03-18
4
M
0
1000
27.48
A
32575
D
Common Stock
2019-03-18
4
S
0
1000
75.122
D
31575
D
Common Stock
2019-03-19
4
M
0
1800
27.48
A
33375
D
Common Stock
2019-03-19
4
M
0
1400
27.00
A
34775
D
Common Stock
2019-03-19
4
M
0
1500
31.98
A
36275
D
Common Stock
2019-03-19
4
S
0
4700
75.00
D
31575
D
Employee Stock Option (right to buy) Holding
27.48
2019-03-18
4
M
0
1000
0.00
D
2027-01-31
Common Stock
1000
45453
D
Employee Stock Option (right to buy) Holding
27.48
2019-03-19
4
M
0
1800
0.00
D
2027-01-31
Common Stock
1800
43653
D
Employee Stock Option (right to buy)
31.98
2019-03-19
4
M
0
1500
0.00
D
2025-01-01
Common Stock
1500
77167
D
Employee Stock Option (right to buy) Holding
27.00
2019-03-19
4
M
0
1400
0.00
D
2026-02-16
Common Stock
1400
17767
D
Includes an aggregate of 13,381 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on December 10, 2018.
Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Represents weighted average sale price. Actual sale prices ranged from $75.11 to $75.13.
Represents actual sale price.
The option became exercisable as to 25% of the shares on January 31, 2018, and becomes exercisable as to 1/48th of the shares each full month thereafter.
The option became exercisable as to 25% of the shares on January 1, 2016, and became exercisable as to 1/48th of the shares each full month thereafter.
The option became exercisable as to 25% of the shares on February 16, 2017, and became exercisable as to 1/48th of the shares each full month thereafter.
/s/ Jason W. Radford, Attorney-in-fact
2019-03-19